Showing results (161-170 of 184) with videos related to
Sort By:
Pageof 19
The Lancet. Neurology|September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trialPedro M Machado, Michael P McDermott, Thomas Blaettler, et al.Annals of Neurology|September 22, 2007
Molecular consequences of dominant Bethlem myopathy collagen VI mutationsNaomi L Baker, Matthias Mörgelin, Rishika A Pace, et al.Annals of Neurology|September 11, 2009
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIPetra Kaufmann, John L P Thompson, Gilberto Levy, et al.Muscle & Nerve|December 22, 2018
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravisKatherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, et al.Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALSPaul H Gordon, Ying-Kuen Cheung, Bruce Levin, et al.Neurobiology of Aging|September 6, 2016
Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositisQiang Gang, Conceição Bettencourt, Pedro M Machado, et al.Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.Journal of Comparative Effectiveness Research|August 28, 2020
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophyCraig Campbell, Richard J Barohn, Enrico Bertini, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 26, 2014
ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristicsHiroshi Mitsumoto, Pam Factor-Litvak, Howard Andrews, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 7, 2017
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major SubgroupsIngrid E Lundberg, Anna Tjärnlund, Matteo Bottai, et al.Pageof 19